Literature DB >> 33977413

Evaluation of the Hologic Panther Fusion MRSA Assay for the detection of MRSA in ESwab specimens obtained from nose, throat, and perineum.

Mette Damkjær Bartels1, Danah Knudsen2, Henrik Westh2,3, Kristian Schønning2,3.   

Abstract

Enrichment culture (EC) remains gold standard for detecting MRSA colonisation, but molecular methods shorten turnaround time. The CE-marked automated Hologic Panther Fusion MRSA Assay (HPFM) is validated for nasal swabs. We compared HPFM with EC following an in-house PCR for detection of MRSA in nasal, pharyngeal, and perineal ESwabs. The same ESwabs were analysed using HPFM and inoculated in selective Tryptic Soy Broth (TSB) for overnight incubation. TSBs were screened by a PCR targeting nuc, femA, mecA, and mecC. Only samples with PCR results compatible with MRSA presence were inoculated onto 5% blood agar and chromogenic MRSA plates. HPFM detected MRSA in 103 of 132 EC positive samples indicating a sensitivity of 78.0% across sample types. When paired TSBs of 29 EC positive/HPFM negative samples were re-analysed by HPFM, MRSA was detected in 17/29 TSBs indicating that enrichment will increase the sensitivity of HPFM. HPFM analyses of cultured isolates from the remaining 12 EC positive/HPFM negative samples failed to detect orfX. HPFM reported the presence of MRSA in 22 samples where EC failed to identify MRSA. Fifteen of these ESwabs had been kept and direct culture without enrichment identified MRSA in seven samples. HPFM was useful for all sample sites. Compared to EC, the sensitivity of HPFM was limited because of lack of analytical sensitivity and failure to detect all MRSA variants. Failure of some MRSA-containing samples to enrich in cefoxitin-containing TSB indicates an unappreciated limitation of EC, which may lead to underestimation of the specificity of molecular assays.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Culture; Hologic Panther Fusion MRSA Assay; MRSA; Perineum; Pharyngeal

Mesh:

Year:  2021        PMID: 33977413     DOI: 10.1007/s10096-021-04272-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Use of broth enrichment and real-time PCR to exclude the presence of methicillin-resistant Staphylococcus aureus in clinical samples: a sensitive screening approach.

Authors:  P Nilsson; H Alexandersson; T Ripa
Journal:  Clin Microbiol Infect       Date:  2005-12       Impact factor: 8.067

2.  Performance of three generations of Xpert MRSA in routine practice: approaching the aim?

Authors:  H Jacqmin; A Schuermans; S Desmet; J Verhaegen; V Saegeman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-20       Impact factor: 3.267

Review 3.  Preventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals.

Authors:  Jesper Larsen; Michael Z David; Margreet C Vos; Geoffrey W Coombs; Hajo Grundmann; Stephan Harbarth; Andreas Voss; Robert L Skov
Journal:  J Glob Antimicrob Resist       Date:  2014-10-02       Impact factor: 4.035

4.  Eradicating MRSA carriage: the impact of throat carriage and Panton-Valentine leukocidin genes on success rates.

Authors:  Kristian Bagge; Thomas Benfield; Henrik Westh; Mette D Bartels
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-25       Impact factor: 3.267

5.  Updating benchtop sequencing performance comparison.

Authors:  Sebastian Jünemann; Fritz Joachim Sedlazeck; Karola Prior; Andreas Albersmeier; Uwe John; Jörn Kalinowski; Alexander Mellmann; Alexander Goesmann; Arndt von Haeseler; Jens Stoye; Dag Harmsen
Journal:  Nat Biotechnol       Date:  2013-04       Impact factor: 54.908

6.  Implications of targeted versus universal admission screening for meticillin-resistant Staphylococcus aureus carriage in a London hospital.

Authors:  J A Otter; Olga Tosas-Auguet; M T Herdman; B Williams; D Tucker; J D Edgeworth; G L French
Journal:  J Hosp Infect       Date:  2014-05-10       Impact factor: 3.926

7.  Performance of the Hologic Panther Fusion® MRSA Assay for the nasal screening of methicillin-sensitive and methicillin-resistant Staphylococcus aureus carriage.

Authors:  Eugénie Maurin; Anne-Gaëlle Ranc; Lelia Abad; Michèle Bes; Claude-Alexandre Gustave; François Vandenesch; Céline Dupieux-Chabert; Anne Tristan; Frédéric Laurent
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-08       Impact factor: 3.267

8.  Semi-selective broth improves screening for methicillin-resistant Staphylococcus aureus.

Authors:  S Böcher; B Middendorf; H Westh; A Mellmann; K Becker; R Skov; A W Friedrich
Journal:  J Antimicrob Chemother       Date:  2010-02-03       Impact factor: 5.790

9.  Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout Mutants.

Authors:  Rodrigo E Mendes; Amy A Watters; Paul R Rhomberg; David J Farrell; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2015-11-04       Impact factor: 5.948

10.  Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.

Authors:  Alessandro Cassini; Liselotte Diaz Högberg; Diamantis Plachouras; Annalisa Quattrocchi; Ana Hoxha; Gunnar Skov Simonsen; Mélanie Colomb-Cotinat; Mirjam E Kretzschmar; Brecht Devleesschauwer; Michele Cecchini; Driss Ait Ouakrim; Tiago Cravo Oliveira; Marc J Struelens; Carl Suetens; Dominique L Monnet
Journal:  Lancet Infect Dis       Date:  2018-11-05       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.